Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Black ginseng (Kyoung Bang Pharmaceutical) is a natural product-based health functional food ingredient currently under development by Kyoung Bang Pharmaceutical. Black ginseng is produced by repeatedly steaming and drying ginseng (Panax ginseng), a process that alters its chemical profile and increases the concentration of specific ginsenosides such as Rg3, Rk1, and Rg5. This R&D project focuses on the application of black ginseng for multiple health indications, including brain disease (neuroprotection), bone health (bone density support), intestinal disease (gastrointestinal health), and liver health. In the South Korean regulatory context, it is classified as a health functional food (건강기능식품), intended to provide physiological benefits and support health maintenance rather than acting as a conventional pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on black ginseng (Kyoung Bang Pharmaceutical).